Identification |
Name: | 6-[2-tert-Butyl-5-(6-methyl-pyridin-2-yl)-1H-imidazol-4-yl]-quinoxaline |
Synonyms: | 6-[2-tert-Butyl-5-(6-methyl-pyridin-2-yl)-1H-imidazol-4-yl]-quinoxaline;SB-525334 |
CAS: | 356559-20-1 |
Molecular Formula: | C21H21N5 |
Molecular Weight: | 0 |
InChI: | InChI=1/C21H21N5/c1-13-6-5-7-16(24-13)19-18(25-20(26-19)21(2,3)4)14-8-9-15-17(12-14)23-11-10-22-15/h5-12,19H,1-4H3 |
Molecular Structure: |
|
Properties |
Transport: | UN 2811 6.1/PG 3 |
Flash Point: | 265.453°C |
Boiling Point: | 515.314°C at 760 mmHg |
Density: | 1.218g/cm3 |
Refractive index: | 1.661 |
Biological Activity: | Selective inhibitor of transforming growth factor- β receptor I (ALK5, TGF- β RI) (IC 50 = 14.3 nM). Inhibits TGF- β 1-induced smad2/3 nuclear localisation and TGF- β 1-induced mRNA expression in kidney cells. Attenuates bleomycin-induced pulmonary fibrosis. |
Flash Point: | 265.453°C |
Storage Temperature: | 2-8°C |
Safety Data |
|
|